Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 39Carcinoma, Non-Small-Cell Lung 30Esophageal Squamous Cell Carcinoma 22Carcinoma, Hepatocellular 21Triple Negative Breast Neoplasms 18Squamous Cell Carcinoma of Head and Neck 17Breast Neoplasms 17Advanced Solid Tumor 17Stomach Neoplasms 14Melanoma 14Small Cell Lung Carcinoma 13Colorectal Neoplasms 13Uterine Cervical Neoplasms 12Neoplasms 10Carcinoma, Transitional Cell 10Carcinoma, Renal Cell 10Recurrence 9Solid Tumor 7Sarcoma 7Neoplasm Metastasis 7Liver Neoplasms 7Head and Neck Neoplasms 7Urinary Bladder Neoplasms 5Rectal Neoplasms 5Esophageal Neoplasms 5Advanced Solid Tumors 5Pancreatic Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Cholangiocarcinoma 4

Interventions

Cisplatin 6Radiotherapy 5Fluorouracil 3Docetaxel 3Specimen Handling 2Platinum 2Magnetic Resonance Spectroscopy 2Hydroxyurea 2Drug Therapy 2Celecoxib 2Carboplatin 21,2-diaminocyclohexaneplatinum II citrate 2toripalimab 1dehydroftorafur 1camrelizumab 1antineoplaston AS 2-1 1antineoplaston A10 1X-Rays 1Transurethral Resection of Bladder 1Therapeutics 1Referral and Consultation 1Radiotherapy, Intensity-Modulated 1Radiation 1Nivolumab 1Ipilimumab 1Eucalyptus Oil 1Etoposide 1Erlotinib Hydrochloride 1Endoscopic Mucosal Resection 1Coal Tar 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Paranasal Sinus Neoplasms × toripalimab × Clear all
NCT06940180 2025-06-26

Toripalimab With Chemotherapy for Sinus Cancer

Dana-Farber Cancer Institute

Phase 2 Recruiting
20 enrolled
Head & Neck

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡